Anne-Marie Koop

98 Eur Heart J Cardiovasc Imaging England; 2014;15:666–672. 68. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoeven AJM, Duncker DJ, Helbing WA, Lamers JMJ. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Mol Cell Cardiol M. Dalinghaus, Erasmus MC-Sophia, Department of Pediatrics, Division of Pediatric Cardiology, 3015 GJ Rotterdam, Netherlands; 2007;43:197–209. 69. Baandrup JD, Markvardsen LH, Peters CD, Schou UK, Jensen JL, Magnusson NE, Ørntoft TF, Kruhøffer M, Simonsen U. Pressure load: The main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic rats. PLoS One U. Simonsen, Department of Pharmacology, Aarhus University, Aarhus, Denmark; 2011;6. 70. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Dekkers DHW, Duncker DJ, Helbing WA, Lamers JMJ. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: Correlations with the degree of hypertrophy. Proteomics J.M.J. Lamers, Department of Biochemistry, Cardiovascular Research School COEUR, Erasmus MC, 3000 DR Rotterdam, Netherlands; 2005;5:2519–2530. 71. Wong YY, Raijmakers P, Campen J Van, Laarse WJ Van Der, Knaapen P, Lubberink M, Ruiter G, Noordegraaf A V, Lammertsma AA. 11C-acetate clearance as an index of oxygen consumption of the right myocardium in idiopathic pulmonary arterial hypertension: A validation study using 15O-labeled tracers and PET. J Nucl Med A.A. Lammertsma, Department of Nuclear Medicine and PET Research, VU University Medical Center, 1081 BT Amsterdam, Netherlands; 2013;54:1258–1262. 72. Yoshinaga K, Ohira H, Tsujino I, Oyama-Manabe N, Mielniczuk L, Beanlands RSB, Katoh C, Kasai K, Manabe O, Sato T, Fujii S, Ito YM, Tomiyama Y, Nishimura M, Tamaki N. Attenuated right ventricular energetics evaluated using 11C-acetate PET in patients with pulmonary hypertension. Eur J Nucl Med Mol Imaging K. Yoshinaga, Department of Molecular Imaging, Hokkaido University, Graduate School of Medicine, Kita-Ku 060-8638m Sapporo Hokkaido, Japan; 2014;41:1240–1250. 73. Matsushita T, Ikeda S, Miyahara Y, Yakabe K, Yamaguchi K, Furukawa K, Iwasaki T, Shikuwa M, Fukui J, Kohno S. Use of [123I]-BMIPPmyocardial scintigraphy for the clinical evaluation of a fatty-acid metabolism disorder of the right ventricle in chronic respiratory and pulmonary vascular disease. J Int Med Res T. Matsushita, Second Dept. of Internal Medicine, Nagasaki University School of Med., Nagasaki 852-8501, Japan; 2000;28:111–123. 74. Sakao S, Miyauchi H, Voelkel NF, Sugiura T, Tanabe N, Kobayashi Y, Tatsumi K. Increased right ventricular fatty acid accumulation in chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc S. Sakao, Department of Respirology (B2), Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan; 2015;12:1465–1472. 75. Nagaya N, Goto Y, Satoh T, Uematsu M, Hamada S, Kuribayashi S, Okano Y, Kyotani S, Shimotsu Y, Fukuchi K, Nakanishi N, Takamiya M, Ishida Y. Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. J Nucl Med Y. Goto, Division of Cardiology, Department of Medicine, National Cardiovascular Center, Suita, Osaka 565, Japan; 1998;39:1676–1680. 76. Drake JI, Gomez-Arroyo J, Dumur CI, Kraskauskas D, Natarajan R, Bogaard HJ, Fawcett P, Voelkel NF. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. Physiol Genomics N. F. Voelkel, Richmond, VA 23298, United States; 2013;45:449–461.